BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiang S, Oliva E. Cytogenetic and molecular aberrations in endometrial stromal tumors. Human Pathology 2011;42:609-17. [DOI: 10.1016/j.humpath.2010.12.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 de Almeida BC, Dos Anjos LG, Dobroff AS, Baracat EC, Yang Q, Al-Hendy A, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines 2022;10:2567. [PMID: 36289829 DOI: 10.3390/biomedicines10102567] [Reference Citation Analysis]
2 Dessources K, Miller KM, Kertowidjojo E, Da Cruz Paula A, Zou Y, Selenica P, da Silva EM, Benayed R, Ashley CW, Abu-rustum NR, Dogan S, Soslow RA, Hensley ML, Weigelt B, Chiang S. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment. Mod Pathol. [DOI: 10.1038/s41379-021-01003-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
4 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
5 Makise N, Sekimizu M, Kobayashi E, Yoshida H, Fukayama M, Kato T, Kawai A, Ichikawa H, Yoshida A. Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion. Virchows Arch 2019;475:527-31. [PMID: 31101969 DOI: 10.1007/s00428-019-02588-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
6 Wang W, Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. Practical Soft Tissue Pathology: a Diagnostic Approach 2019. [DOI: 10.1016/b978-0-323-49714-5.00018-1] [Reference Citation Analysis]
7 Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, Liberati M, Rosini S. Uterine Sarcomas: An Updated Overview. Neoplasm 2018. [DOI: 10.5772/intechopen.78980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
9 Wojcik J, Cooper K. Epigenetic Alterations in Bone and Soft Tissue Tumors. Adv Anat Pathol 2017;24:362-71. [PMID: 28885261 DOI: 10.1097/PAP.0000000000000167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ritterhouse LL, Howitt BE. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors. Surg Pathol Clin 2016;9:405-26. [PMID: 27523969 DOI: 10.1016/j.path.2016.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
11 Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
12 Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 2017;30:1251-61. [PMID: 28621321 DOI: 10.1038/modpathol.2017.42] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
13 Howitt BE, Dal Cin P, Nucci MR, Quade BJ. Involvement of Chromosome 8 in Müllerian Adenosarcoma: . International Journal of Gynecological Pathology 2017;36:24-30. [DOI: 10.1097/pgp.0000000000000287] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Howitt BE, Nucci MR. Molecular Pathology of Uterine Mesenchymal Tumors. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_11] [Reference Citation Analysis]
15 Rommel B, Holzmann C, Bullerdiek J. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification. Expert Rev Anticancer Ther 2016;16:1155-66. [PMID: 27602604 DOI: 10.1080/14737140.2016.1233817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Stewart CJ, Crook M, Tan A. SF1 immunohistochemistry is useful in differentiating uterine tumours resembling sex cord-stromal tumours from potential histological mimics. Pathology. 2016;48:434-440. [PMID: 27311867 DOI: 10.1016/j.pathol.2016.03.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
17 Uterine Sarcomas. Diagnostic Pathology: Molecular Oncology 2016. [DOI: 10.1016/b978-0-323-37678-5.50175-4] [Reference Citation Analysis]
18 Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S, Selle F, Small W, Witteveen E, Russell P. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer 2014;24:S78-82. [PMID: 25341585 DOI: 10.1097/IGC.0000000000000239] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
19 Chiang S, Staats PN, Senz J, Kommoss F, De Nictolis M, Huntsman DG, Gilks CB, Oliva E. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors. Am J Surg Pathol 2015;39:618-23. [PMID: 25581731 DOI: 10.1097/PAS.0000000000000367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
20 Oznur M, Dede S, Barh D, Gunduz M. Cytogenetic Early Markers in Gynecologic Cancers. Noninvasive Molecular Markers in Gynecologic Cancers 2015. [DOI: 10.1201/b18015-4] [Reference Citation Analysis]
21 Ali RH, Rouzbahman M. Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol. 2015;68:325-332. [PMID: 25595274 DOI: 10.1136/jclinpath-2014-202829] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
22 Rajanbabu A. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas. Uterine Cancer 2015. [DOI: 10.1007/978-81-322-1892-0_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Soslow RA, Oliva E. Uterine Cancer: Pathology. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_7] [Reference Citation Analysis]
24 Collin F, de Saint Aubain N. [Intra-abdominal soft tissue tumors. What needs to be known to reach the diagnosis with the help of immunohistochemistry, FISH and molecular biology]. Ann Pathol 2015;35:114-25. [PMID: 25541116 DOI: 10.1016/j.annpat.2014.11.007] [Reference Citation Analysis]
25 Tokinaga A, Furuya M, Niino H, Udaka N, Asai-Sato M, Sekido H, Miyagi E. Colonic low-grade endometrial stromal sarcoma and orthotopic endometrial stromal tumor with limited infiltration sharing the JAZF1-SUZ12 gene fusion. Pathol Int 2014;64:178-82. [PMID: 24750188 DOI: 10.1111/pin.12151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Schmeler KM, Rauh-hain JA, del Carmen MG. Endometrial Stromal Sarcomas. Uncommon Gynecologic Cancers 2014. [DOI: 10.1002/9781118655344.ch19] [Reference Citation Analysis]
27 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
28 Jividen K, Li H. Chimeric RNAs generated by intergenic splicing in normal and cancer cells. Genes Chromosomes Cancer 2014;53:963-71. [PMID: 25131334 DOI: 10.1002/gcc.22207] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
29 Stewart CJR, Leung YC, Murch A, Peverall J. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases. Histopathology 2014;65:473-82. [DOI: 10.1111/his.12406] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
30 Micci F, Gorunova L, Gatius S, Matias-Guiu X, Davidson B, Heim S, Panagopoulos I. MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma. Cancer Lett 2014;347:75-8. [PMID: 24530230 DOI: 10.1016/j.canlet.2014.01.030] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
31 Stemme S, Ghaderi M, Carlson JW. Diagnosis of endometrial stromal tumors: a clinicopathologic study of 25 biopsy specimens with identification of problematic areas. Am J Clin Pathol 2014;141:133-9. [PMID: 24343747 DOI: 10.1309/AJCPXD0TPYSNVI8I] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
32 Rauh-Hain JA, del Carmen MG. Endometrial stromal sarcoma: a systematic review. Obstet Gynecol. 2013;122:676-683. [PMID: 23921879 DOI: 10.1097/AOG.0b013e3182a189ac] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
33 Sivridis E, Giatromanolaki A. Demystifying endometrial hyperplasia. Diagnostic Histopathology 2013;19:223-230. [DOI: 10.1016/j.mpdhp.2013.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013;62:124-37. [PMID: 23240674 DOI: 10.1111/his.12048] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
35 Sivridis E, Koutsougeras G, Giatromanolaki A. Endometrial stromal hyperplasia: an underrecognized condition. Case Rep Pathol 2013;2013:204082. [PMID: 23710401 DOI: 10.1155/2013/204082] [Reference Citation Analysis]
36 Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg L, Schairer C, Ou Shu X, van den Brandt PA, Virkus RA, Wentzensen N, Xiang YB, Xu WH, Yang HP, Brinton LA. The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 2013;108:727-34. [PMID: 23348519 DOI: 10.1038/bjc.2013.2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
37 Cooley LD, Wilson KS. The Cytogenetics of Solid Tumors. The Principles of Clinical Cytogenetics 2013. [DOI: 10.1007/978-1-4419-1688-4_16] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Lax S. Erkrankungen des Endometriums. Pathologie 2013. [DOI: 10.1007/978-3-642-04564-6_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. Practical Soft Tissue Pathology: A Diagnostic Approach 2013. [DOI: 10.1016/b978-1-4160-5455-9.00018-1] [Reference Citation Analysis]
40 Duvillard P. [Gynecopathology. Case 8. Undifferentiated endometrial sarcoma]. Ann Pathol 2012;32:214-6. [PMID: 22748340 DOI: 10.1016/j.annpat.2012.04.008] [Reference Citation Analysis]
41 Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S. Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS One 2012;7:e39354. [PMID: 22761769 DOI: 10.1371/journal.pone.0039354] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 8.2] [Reference Citation Analysis]
42 Higashiura Y, Kajihara H, Shigetomi H, Kobayashi H. Identification of multiple pathways involved in the malignant transformation of endometriosis (Review). Oncol Lett 2012;4:3-9. [PMID: 22807950 DOI: 10.3892/ol.2012.690] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
43 Teicher BA. Searching for molecular targets in sarcoma. Biochem Pharmacol. 2012;84:1-10. [PMID: 22387046 DOI: 10.1016/j.bcp.2012.02.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
44 Xue W, Cheung AN. Endometrial stromal sarcoma of uterus. Best Practice & Research Clinical Obstetrics & Gynaecology 2011;25:719-32. [DOI: 10.1016/j.bpobgyn.2011.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]